Peptides for Skin & Sexual Health: GHK-Cu, PT-141, Melanotan II and More

You’ll find peptides in two very different places, 1) In skincare you rub on, and 2) In injectable off-label compounds people use (for a purpose the product was never approved for) to boost sexual desire or get a tan.

The two groups can’t be swapped for each other. They also don’t share the same evidence, approval status, or oversight. A copper peptide in your moisturizer and an unapproved injectable sold online with no prescription are both “peptides,” but that’s nearly all they have in common.

This report covers what has actually been studied and which of these compounds are FDA-approved. For each compound, it also covers who’s selling it and what that sales channel tells you.

What “peptides” means here: Two different categories, not one

A peptide is a short chain of amino acids, the same building blocks your body uses to make proteins. Your body makes thousands of peptides naturally. Each one works like a small chemical message that tells certain cells to do something.

The peptides in this report fall into two groups:

• Topical (cosmetic) peptides. These go on your skin in creams and serums. Examples include GHK-Cu, Argireline, and Matrixyl. They’re sold as cosmetic ingredients, and their effects are meant to stay in the skin.
• Injectable (systemic) peptides. These are injected under the skin and travel through your bloodstream to act on the whole body, including your brain. Examples include PT-141 (bremelanotide) and Melanotan II. They’re regulated as drugs, whether or not they’ve been approved as one.

One quick point to clear up confusion: “collagen peptides,” the powders you stir into coffee, are a separate thing. They’re a dietary supplement you swallow, and this report doesn’t cover them.

Peptides for skin: what’s actually in your skincare

Skincare peptides mostly aim at the visible signs of aging: fine lines, wrinkles, and skin that has lost some firmness. The evidence for them is real, but thin. Most of it comes from small clinical trials that ran for only a few weeks, as summarized in a 2025 review in Biomolecules.

GHK-Cu (copper peptides)

GHK-Cu is a tiny peptide, just three amino acids, attached to a copper atom. It occurs naturally in human blood, and levels drop as you age. In lab and animal research, GHK-Cu helps with wound healing and signals skin cells to make more collagen, the protein that keeps skin firm (Pickart & Margolina, 2018).

The human evidence is thinner. It’s mostly small trials of topical creams that measured wrinkle depth over about 8 weeks (Biomolecules review, 2025). Evidence tier: moderate lab evidence, limited human evidence.

Who sells it: Nearly all GHK-Cu is sold in over-the-counter skincare at drugstores and on brand websites, and you don’t need a prescription. A separate, much smaller market sells injectable GHK-Cu through “research use only” websites. Those sites sell directly to consumers with no prescription and no medical oversight. It’s the same molecule, but the channel is completely different. We cover that difference below.

Argireline (acetyl hexapeptide-8)

Argireline is often described as “topical Botox,” and that comparison oversells it. It’s designed to mimic part of a protein that nerves use to tell facial muscles to contract, with the goal of softening the repeated muscle movement behind expression lines. Botox is an injected drug that reliably blocks that signal. Argireline is a cream ingredient, and it has to get through the skin’s outer barrier before it can do anything.

Small human trials, some lasting only 4 weeks, have reported less visible wrinkling than a placebo (an inactive cream used for comparison) (Biomolecules review, 2025). Evidence tier: limited human evidence.

Who sells it: Argireline is sold only in over-the-counter skincare at drugstores and on brand websites, with no prescription.

Matrixyl (palmitoyl pentapeptide-4)

Matrixyl is a “signal peptide,” meaning it’s built to look like a fragment of broken-down collagen. The idea is that skin cells read that fragment as a sign of damage and respond by making fresh collagen.

The best-known study was a 12-week, placebo-controlled trial in 93 women. Experts who graded the photos saw improvement in fine lines and overall skin appearance (Biomolecules review, 2025). Evidence tier: limited human evidence.

Who sells it: Matrixyl is sold only in over-the-counter skincare at drugstores and on brand websites, with no prescription.

Are skincare peptides FDA-approved?

No, and they aren’t supposed to be. In the U.S., a cosmetic is a product meant to clean or change how you look, and the FDA does not approve cosmetics before they go on sale. A drug is a product meant to treat a condition or change how your body works, and it has to prove it’s safe and effective before it can be sold.

Here’s what that means in practice. A peptide cream has to follow standard cosmetic manufacturing and labeling rules. It doesn’t have to prove it works at the amount on the label. When a jar says “clinically shown to reduce wrinkles,” that claim hasn’t gone through FDA review.

Regulatory status, compound by compound:

• GHK-Cu is regulated as a cosmetic ingredient when sold topically, meaning it’s not a drug and has been neither approved nor rejected as one, as of September 2026. Injectable GHK-Cu is sold separately as research-use-only.
• Argireline is regulated as a cosmetic ingredient, not a drug, as of September 2026.
• Matrixyl is regulated as a cosmetic ingredient, not a drug, as of September 2026.

Peptides for sexual health: PT-141 and bremelanotide (Vyleesi)

PT-141 is the research name for bremelanotide. It’s the only compound that has passed FDA review as a drug. Bremelanotide is FDA-approved under the brand name Vyleesi for hypoactive sexual desire disorder (HSDD), a condition where low sexual desire causes real distress, in premenopausal women, as of September 2026 (FDA label).

Unlike Viagra, which works on blood flow, bremelanotide acts on the brain. It switches on melanocortin receptors, which are docking points on cells that help regulate appetite, skin color, and sexual desire. The FDA label says plainly that it isn’t known exactly how this improves desire (FDA label).

Approval came after two 24-week clinical trials. In those trials, women using bremelanotide reported modestly higher desire and less distress than women on placebo (FDA label). Nausea was the most common side effect, reported by about 40% of users. The label also lists flushing, headache, a temporary rise in blood pressure, and darkening of patches of skin, especially on the face and gums (FDA label). It is not approved for men, for postmenopausal women, or for boosting sexual performance (FDA label).

Who sells it: There are two very different versions on the market.

• Vyleesi. You need a prescription, and it’s filled at a licensed pharmacy for its approved use. That gets you FDA-inspected manufacturing, a verified dose in every injector, and a doctor who has checked whether it’s appropriate for you.
• Unbranded “PT-141.” It’s sold by research-chemical websites and some telehealth or medspa clinics for off-label uses, including for men. None of it has FDA manufacturing oversight. Depending on the seller, you may also get no medical supervision at all.

The name on the vial may be the same, but the guarantees behind it are not.

A brief note on kisspeptin

Kisspeptin is a hormone your brain makes naturally. It acts like a master switch that starts the release of reproductive hormones. Researchers are studying it in fertility treatment and in small brain-imaging studies of sexual and emotional response (JCEM review, 2025; PubMed).

Kisspeptin is not FDA-approved for any human therapeutic use and is not commercially available as an approved drug, as of September 2026. It’s used in research and investigational settings. Who sells it: Outside clinical trials, the only source is “research use only” websites, with no prescription, no medical oversight, and no independent check on what’s in the vial.

Melanotan II: tanning and libido claims, and why it’s different from PT-141

Melanotan II is a lab-made copy of the hormone that tells your skin to produce pigment. People use it to tan without much sun exposure, and some use it for its reported effect on sex drive. It’s closely related to PT-141. Bremelanotide was developed from the same chemical family, and both switch on melanocortin receptors.

The difference is in what happened next. Bremelanotide went through large clinical trials and FDA review for one specific use. Melanotan II never did. Melanotan II is not FDA-approved for any use and is classified as research-use-only, as of September 2026. The FDA has taken enforcement action against sellers of unapproved Melanotan II, stating that such sales put consumers’ health at risk (FDA).

Because there are no large trials, most of what’s known about its safety comes from case reports, which are write-ups of individual patients doctors have seen. Several describe new or changing moles in people using Melanotan II, and at least one describes melanoma, the most serious type of skin cancer (PubMed; PubMed). Case reports can’t prove the drug caused those changes. They also can’t rule it out, and that’s the problem with a compound nobody has studied properly.

Who sells it: Almost all of it comes from “research use only” websites selling directly to consumers. There’s no prescription, no medical oversight, no FDA manufacturing checks, and no independent guarantee that the vial contains what the label says, at the strength it says.

Where these compounds are actually sold, and what that does and doesn’t guarantee

This report covers three very different sales channels. Knowing which one you’re buying through tells you a lot about what you’re getting.

1. The cosmetic aisle (GHK-Cu skincare, Argireline, Matrixyl). These products are sold at drugstores and on brand websites, with no prescription. They follow cosmetic manufacturing and labeling rules. What that doesn’t guarantee is that the product works at the amount in the jar, because cosmetics don’t have to prove effectiveness before they’re sold.

2. Prescription through a licensed pharmacy (Vyleesi). This is the only channel in this guide with full FDA backing. You get inspected manufacturing, an accurate dose, a doctor’s evaluation, and legal protection if something goes wrong with the product. The catch is that it only covers the approved use: HSDD in premenopausal women.

3. “Research use only” websites, plus some telehealth and medspa clinics (unbranded PT-141, Melanotan II, injectable GHK-Cu, kisspeptin). “Research use only” is a label that means the product isn’t meant for people, and it’s often how unapproved compounds get sold online. These sellers guarantee very little: no FDA manufacturing oversight, no independent check on purity or dose, and usually no medical supervision. A clinic may add a doctor’s visit, but that doesn’t turn an unapproved compound into an approved one.

Two mistakes worth avoiding … The first is assuming that because peptide creams are easy to buy and low-risk, injectable peptides must be too. They aren’t the same thing. The second is assuming that an online checkout page means a product has been vetted. It only means someone is selling it.

What the evidence actually shows: evidence-tier comparison

Who these peptides are and aren’t a fit for

Topical peptides are a reasonable, low-stakes option if you want to try something for fine lines and don’t expect dramatic results. They’re sold as cosmetics, so the realistic expectation is a modest improvement, not the results you’d get from prescription treatments like retinoids or procedures a dermatologist does in the office. If you have sensitive skin or a skin condition, ask a dermatologist before adding a new active ingredient.

Bremelanotide (Vyleesi) is meant for one specific group: premenopausal women with HSDD, after a doctor has ruled out other causes such as medication side effects or relationship problems. The FDA label says it isn’t appropriate for people with uncontrolled high blood pressure or known heart disease (FDA label). If you think you might be in that group, a doctor’s appointment is the right next step. A research-chemical website is not.

Melanotan II, injectable GHK-Cu, unbranded PT-141, and kisspeptin don’t have the evidence or the oversight needed to recommend them for anyone outside a supervised clinical study. That’s not a moral judgment. The information you’d need to make a safe decision about them simply doesn’t exist yet.

FAQs about Peptides for Skin and Sexual Health